Regional Access Medis specializes in Central and Eastern Europe and Greece with an integrated commercialization model, offering a ready-made channel for partners seeking regional market access and reimbursement navigation in this fragmented healthcare landscape.

Orphan & Specialty As a member of the World Orphan Drug Alliance and demonstrated strengths in rare and specialty portfolios, Medis can accelerate market entry for partners with orphan or high-need therapies requiring complex access strategies.

OneStop Accountability With a single point of accountability across 19 markets and a proven track record of reimbursement successes, Medis presents a streamlined, lower-risk partnership for regulatory, access, medical, sales, and marketing execution.

KOL and Access Strong relationships with local healthcare professionals and KOLs can shorten payer negotiations and speed patient access, creating faster time-to-market for partner therapeutics in the region.

Diversified Portfolio A diversified business across therapeutics, hospital care, consumer health, and aesthetics, plus out-licensing partners, provides cross-sell opportunities and portfolio-fit synergies for partners looking to expand in multiple adjacent segments.